Phase II Study of Accelerated High-Dose Radiation Therapy with Concurrent Chemotherapy for Patients With Limited Small-Cell Lung Cancer: RTOG 0239

PURPOSE: To investigate whether high-dose thoracic radiation given twice daily during cisplatin–etoposide chemotherapy for limited small cell lung cancer (LSCLC) improves survival, acute esophagitis, and local control rates relative to findings from Intergroup trial 0096 (47%, 27%, and 64%).. PATIEN...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Komaki, Ritsuko, Paulus, Rebecca, Ettinger, David S., Videtic, Gregory M.M., Bradley, Jeffrey D., Glisson, Bonnie S., Langer, Corey J., Sause, William T., Curran, Walter J., Choy, Hak
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3377848/
https://ncbi.nlm.nih.gov/pubmed/22560543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2012.01.075
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares